Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst Holler

Showing results (31-40 of 265) with videos related to

Pageof 27
Sort By:
Biochemical and Biophysical Research Communications|August 26, 2006
Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metaboliteEva Gottfried, Michael Rehli, Joachim Hahn, et al.
Radiation Oncology (London, England)|November 29, 2022
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiationIsabella Gruber, Oliver Koelbl, Wolfgang Herr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 26, 2016
Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational StudyMatthias Grube, Ernst Holler, Daniela Weber, et al.
Transfusion|November 8, 2005
Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood productsAnnelie Plentz, Joachim Hahn, Antje Knöll, et al.
British Journal of Haematology|November 30, 2004
Genetic polymorphisms predicting the outcome of bone marrow transplantsAnne M Dickinson, Peter G Middleton, Vanderson Rocha, et al.
Deutsches Arzteblatt International|November 25, 2011
The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and SwitzerlandDaniel Wolff, Hartmut Bertz, Hildegard Greinix, et al.
Frontiers in Oncology|May 12, 2020
Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory TherapyAnna-Sophia Kattner, Ernst Holler, Wolfgang Herr, et al.
Journal of Medical Virology|October 16, 2004
Quantitation of Epstein-Barr virus mRNA using reverse transcription and real-time PCRBirgit Weinberger, Annelie Plentz, Klaus M Weinberger, et al.
International Journal of Molecular Medicine|August 3, 2007
Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantationPatricia Ewing, Gerhard C Hildebrandt, Simone Planke, et al.
Clinical Transplantation|September 13, 2016
ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantationMatthias Grube, Daniel Wolff, Norbert Ahrens, et al.
Pageof 27

Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
Biochemical and Biophysical Research Communications|August 26, 2006
Monocyte-derived cells express CYP27A1 and convert vitamin D3 into its active metaboliteEva Gottfried, Michael Rehli, Joachim Hahn, et al.
Radiation Oncology (London, England)|November 29, 2022
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiationIsabella Gruber, Oliver Koelbl, Wolfgang Herr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 26, 2016
Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational StudyMatthias Grube, Ernst Holler, Daniela Weber, et al.
Transfusion|November 8, 2005
Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood productsAnnelie Plentz, Joachim Hahn, Antje Knöll, et al.
British Journal of Haematology|November 30, 2004
Genetic polymorphisms predicting the outcome of bone marrow transplantsAnne M Dickinson, Peter G Middleton, Vanderson Rocha, et al.
Deutsches Arzteblatt International|November 25, 2011
The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and SwitzerlandDaniel Wolff, Hartmut Bertz, Hildegard Greinix, et al.
Frontiers in Oncology|May 12, 2020
Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory TherapyAnna-Sophia Kattner, Ernst Holler, Wolfgang Herr, et al.
Journal of Medical Virology|October 16, 2004
Quantitation of Epstein-Barr virus mRNA using reverse transcription and real-time PCRBirgit Weinberger, Annelie Plentz, Klaus M Weinberger, et al.
International Journal of Molecular Medicine|August 3, 2007
Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantationPatricia Ewing, Gerhard C Hildebrandt, Simone Planke, et al.
Clinical Transplantation|September 13, 2016
ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantationMatthias Grube, Daniel Wolff, Norbert Ahrens, et al.
Pageof 27